Back to search
FDAFDA · Food and drugs·Recall number D-0257-2024

Benzonatate Capsules, USP, 100 mg, 100 Capsules (10 capsules x 10 unit dose cards), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC 68084-214-01; Individual Dose NDC 68084-214-11

Published January 31, 2024 · Recall initiated: December 26, 2023

Summary

FDA records drug Class III recall D-0257-2024, published January 31, 2024 and initiated December 26, 2023. Recalling firm: Amerisource Health Services LLC; Status: Ongoing; Reported quantity: 6,344 cartons; Lot: Lot # 1014208, Exp Mar/31/2025. Class III means the product is not likely to cause adverse health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Superpotent drug: Assay results were slightly above specification at the time zero point.

What to do

Voluntary: Firm initiated · Letter

Get an email if BENZONATATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
BENZONATATE
Manufacturer
Amerisource Health Services LLC
Distributor
Nationwide in the USA
Lot
Lot # 1014208, Exp Mar/31/2025
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Benzonatate Capsules, USP, 100 mg, 100 Capsules (10 capsules x 10 unit dose cards), Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217. Carton NDC 68084-214-01; Individual Dose NDC 68084-214-11 recalled?

Yes. FDA published recall D-0257-2024 on January 31, 2024. Reported hazard: Superpotent drug: Assay results were slightly above specification at the time zero point.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: BENZONATATE.